Xtx Topco LTD Arcellx, Inc. Transaction History

Xtx Topco LTD

$2.23 Billion
Q2 2025

A detailed history of Xtx Topco LTD transactions in Arcellx, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 16,787 shares of ACLX stock, worth $1.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

16,787

Holding current value

$1.43 Million

% of portfolio

0.05%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2025 Aug 12, 2025	BUY	$52.8 - $68.1 $886,353 - $1.14 Million	16,787 New	16,787 $1.11 Million
Q1 2024 May 13, 2024	BUY	$51.85 - $73.49 $210,614 - $298,516	4,062 New	4,062 $282,000

Others Institutions Holding ACLX

# of Institutions

219

Shares Held

49.1M

Call Options Held

245K

Put Options Held

885K

Paradigm Biocapital Advisors LP New York, NY

4.65M
Shares

$395 Million
14.29% of portfolio
Vanguard Group Inc Valley Forge, PA

3.94M
Shares

$336 Million
0.0% of portfolio
Nea Management Company, LLC Timonium, MD

3.75M
Shares

$319 Million
20.45% of portfolio
Black Rock Inc. New York, NY

3.52M
Shares

$299 Million
0.0% of portfolio
Ra Capital Management, L.P. Boston, MA

3.04M
Shares

$258 Million
4.37% of portfolio

View Full List

About Arcellx, Inc.

Ticker ACLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,819,200
Market Cap $3.73B
Description
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...

More about ACLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account